BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 7656819)

  • 1. [p53 gene deletion and abnormal expression in gastric carcinoma].
    Yang D; Li T; Xu W
    Zhonghua Zhong Liu Za Zhi; 1995 May; 17(3):175-8. PubMed ID: 7656819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
    Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
    Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
    Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
    Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of p53 in gastric carcinoma. Prognostic value].
    Sundblad A; Pellicer EM; Mehta P; Ahn C; Battifora H
    Medicina (B Aires); 1994; 54(3):216-20. PubMed ID: 7854087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of p53 predicts shorter survival in diffuse type gastric cancer.
    Lee WJ; Shun CT; Hong RL; Wu MS; Chang KJ; Chen KM
    Br J Surg; 1998 Aug; 85(8):1138-42. PubMed ID: 9718015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer.
    Ichiyoshi Y; Oiwa H; Tomisaki S; Sakaguchi Y; Ohno S; Maehara Y; Sugimachi K
    Hepatogastroenterology; 1997; 44(14):546-53. PubMed ID: 9164535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
    Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gastric cancer with P53 overexpression and nm23 low-expression has high potential for lymph node metastasis].
    Zhang S; Ye S; Lin H
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):418-21. PubMed ID: 8697991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-associated increase of codon 72 Arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma.
    Zhang ZW; Newcomb P; Hollowood A; Feakins R; Moorghen M; Storey A; Farthing MJ; Alderson D; Holly J
    Clin Cancer Res; 2003 Jun; 9(6):2151-6. PubMed ID: 12796380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation between the expression of p53 protein and DNA ploidy in patients with gastric cancer that has invaded the serosa.
    Wang Z; Ikeguchi M; Maeta M; Kaibara N
    Anticancer Res; 1997; 17(5A):3701-5. PubMed ID: 9413227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study on expression of tumor suppressor gene p53 in endometrial carcinoma].
    Xue F; Jiao S; Zhao F
    Zhonghua Fu Chan Ke Za Zhi; 1995 Nov; 30(11):647-50. PubMed ID: 8745486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma.
    Song KY; Jung CK; Park WS; Park CH
    Jpn J Clin Oncol; 2009 May; 39(5):290-6. PubMed ID: 19336448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of p53 protein expression for patients with gastric cancer--a multivariate analysis.
    Maehara Y; Tomoda M; Hasuda S; Kabashima A; Tokunaga E; Kakeji Y; Sugimachi K
    Br J Cancer; 1999 Mar; 79(7-8):1255-61. PubMed ID: 10098768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of p53 gene in gastric carcinoma in Taiwan.
    Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
    Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between alterations of p16INK4a and p14ARF genes of CDKN2A locus and gastric carcinogenesis].
    Tang SH; Yang DH; Luo HS; Yu JP; Shu JC
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):517-21. PubMed ID: 15231134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
    Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
    Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic evidence for the multicentric origin of synchronous multiple gastric carcinoma.
    Kang GH; Kim CJ; Kim WH; Kang YK; Kim HO; Kim YI
    Lab Invest; 1997 Mar; 76(3):407-17. PubMed ID: 9121123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low presence of p53 abnormalities in H pylori-infected gastric mucosa and in gastric adenocarcinoma.
    Berloco P; Russo F; Cariola F; Gentile M; Giorgio P; Caruso ML; Valentini AM; Di Matteo G; Di Leo A
    J Gastroenterol; 2003; 38(1):28-36. PubMed ID: 12560919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mutation of p53 gene in human cancers of the esophagus and gastric cardia].
    Li HC; Lu SX
    Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):172-6. PubMed ID: 7956692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
    Hashimoto T; Tokuchi Y; Hayashi M; Kobayashi Y; Nishida K; Hayashi S; Ishikawa Y; Tsuchiya S; Nakagawa K; Hayashi J; Tsuchiya E
    Cancer Res; 1999 Nov; 59(21):5572-7. PubMed ID: 10554037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.